Company Pharma Med Srl with Fiscal Code 15427817
recorded a turnover of 2024 of
207.601,
with a net profit of
122.484
and having an average number of employees of
3.
The company operates in the field of Lucrări de construcţii a clădirilor rezidenţiale şi nerezidenţiale having the NACE code 4100.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Pharma Med Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
420.395
416.572
343.026
231.320
322.924
72.424
148.830
139.177
125.688
207.601
Total Income - EUR
427.890
428.954
479.815
232.468
934.795
83.979
189.418
165.495
436.865
251.227
Total Expenses - EUR
411.649
396.732
345.673
257.281
351.161
195.468
176.270
133.848
314.688
122.770
Gross Profit/Loss - EUR
16.241
32.223
134.142
-24.813
583.634
-111.488
13.148
31.647
122.178
128.456
Net Profit/Loss - EUR
13.589
27.067
124.642
-27.138
574.644
-112.157
11.364
30.112
117.890
122.484
Employees
4
4
3
7
7
9
9
5
2
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 66.1%, from 125.688 euro in the year 2023, to 207.601 euro in 2024.
The Net Profit increased by 5.252 euro, from 117.890 euro in 2023, to 122.484 in the last year.
Check the financial reports for the company - Pharma Med Srl
Financial Rating - PHARMA MED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Pharma Med Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Pharma Med Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Pharma Med Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Pharma Med Srl - CUI 15427817
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
5.855
9.053
179.587
173.325
311.922
636.526
693.319
675.566
691.774
807.630
Current Assets
200.808
250.045
60.881
189.305
589.259
173.874
203.349
83.679
206.860
171.634
Inventories
77.546
96.003
0
52.144
95.731
60.356
22.595
8.572
12.589
8.507
Receivables
106.612
96.557
54.227
79.353
506.187
112.141
124.422
114.874
176.779
143.075
Cash
16.650
55.259
4.465
57.808
-12.659
1.377
56.332
22.810
17.492
20.052
Shareholders Funds
105.805
148.262
207.601
154.034
725.695
514.702
486.902
521.081
696.917
815.505
Social Capital
38.470
38.078
37.434
36.747
36.035
35.352
34.568
34.675
109.168
108.558
Debts
100.858
110.835
32.867
208.597
170.771
276.257
374.986
203.274
164.423
126.672
Income in Advance
0
0
0
0
4.715
19.441
34.780
34.889
37.295
37.086
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4100 - 4100"
CAEN Financial Year
4120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
171.634 euro in 2024 which includes Inventories of
8.507 euro, Receivables of
143.075 euro and cash availability of
20.052 euro.
The company's Equity was valued at
815.505 euro, while total Liabilities amounted to
126.672 euro.
Equity increased by 122.484 euro, from 696.917 euro in 2023, to 815.505 in 2024.
The Debt Ratio was 12.9% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Pharma Med Srl